Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Regen Biopharma, Inc. (RGBP)
:RGBP
Holding RGBP?
Track your performance easily
RGBP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.60
Previous CloseN/A
Volume4.72K
Average Volume (3M)31.35K
Market Cap
$705.17K
Enterprise ValueN/A
Total Cash (Recent Filing)$269.97K
Total Debt (Recent Filing)$332.41K
Price to Earnings (P/E)―
Beta1.76
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Jul 05, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding10,016,640
10 Day Avg. Volume10,288
30 Day Avg. Volume31,349
Standard Deviation0.96
R-Squared0.02
Alpha0.13
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.56
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Regen Biopharma News
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
RGBP FAQ
What was Regen Biopharma, Inc.’s price range in the past 12 months?
Regen Biopharma, Inc. lowest stock price was $0.02 and its highest was $0.60 in the past 12 months.
What is Regen Biopharma, Inc.’s market cap?
Regen Biopharma, Inc.’s market cap is $705.17K.
When is Regen Biopharma, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Regen Biopharma, Inc.’s earnings last quarter?
Regen Biopharma, Inc. released its earnings results on May 14, 2018. The company reported -$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.008.
Is Regen Biopharma, Inc. overvalued?
According to Wall Street analysts Regen Biopharma, Inc.’s price is currently Overvalued.
Does Regen Biopharma, Inc. pay dividends?
Regen Biopharma, Inc. pays a Notavailable dividend of $0.057 which represents an annual dividend yield of N/A. See more information on Regen Biopharma, Inc. dividends here
What is Regen Biopharma, Inc.’s EPS estimate?
Regen Biopharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regen Biopharma, Inc. have?
Regen Biopharma, Inc. has 10,016,640 shares outstanding.
What happened to Regen Biopharma, Inc.’s price movement after its last earnings report?
Regen Biopharma, Inc. reported an EPS of -$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Regen Biopharma, Inc.?
Currently, no hedge funds are holding shares in RGBP
---
Company Description
Regen Biopharma, Inc.
Regen Biopharma, Inc. engages in the development of regenerative medical applications licensed from other companies. It focuses on the immunology and immonutherapy research for the areas of Hematopoiesis, Breast Cancer, Liver Cancer, Leukemia, Myelodysplastic Syndrome, and Aplastic Anemia. The company was founded on April 24, 2012 and is headquartered in La Mesa, CA.
---
Technical Analysis
Advaxis
―
Cyclacel Pharmaceuticals
―
Plus Therapeutics
―
Verastem
―
Bioxcel Therapeutics
―
---